A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

NCT05042362 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

396

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms Associated With Menopause
Hot Flashes

Interventions

DRUG: Elinzanetant (BAY3427080)
DRUG: Placebo

Sponsor

Bayer